Home Other Building Blocks Temocapril HCl

Temocapril HCl

CAS No.:
110221-44-8
Catalog Number:
AG01CCL0
Molecular Formula:
C23H29ClN2O5S2
Molecular Weight:
513.0698
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
5mg
98%
In Stock USA
United States
$54
- +
10mg
98%
In Stock USA
United States
$86
- +
25mg
98%
In Stock USA
United States
$150
- +
50mg
98%
In Stock USA
United States
$262
- +
100mg
98%
In Stock USA
United States
$498
- +
Product Description
Catalog Number:
AG01CCL0
Chemical Name:
Temocapril HCl
CAS Number:
110221-44-8
Molecular Formula:
C23H29ClN2O5S2
Molecular Weight:
513.0698
MDL Number:
MFCD00933433
IUPAC Name:
2-[(2S,6R)-6-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-5-oxo-2-thiophen-2-yl-1,4-thiazepan-4-yl]acetic acid;hydrochloride
InChI:
InChI=1S/C23H28N2O5S2.ClH/c1-2-30-23(29)17(11-10-16-7-4-3-5-8-16)24-18-15-32-20(19-9-6-12-31-19)13-25(22(18)28)14-21(26)27;/h3-9,12,17-18,20,24H,2,10-11,13-15H2,1H3,(H,26,27);1H/t17-,18-,20-;/m0./s1
InChI Key:
XDDQNOKKZKHBIX-ASBZXGSUSA-N
SMILES:
CCOC(=O)C(NC1CSC(CN(C1=O)CC(=O)O)c1cccs1)CCc1ccccc1.Cl
UNII:
8G820I95VP
Properties
Complexity:
644  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
2  
Defined Atom Stereocenter Count:
3  
Defined Bond Stereocenter Count:
0
Exact Mass:
512.121g/mol
Formal Charge:
0
Heavy Atom Count:
33  
Hydrogen Bond Acceptor Count:
8  
Hydrogen Bond Donor Count:
3  
Isotope Atom Count:
0
Molecular Weight:
513.064g/mol
Monoisotopic Mass:
512.121g/mol
Rotatable Bond Count:
11  
Topological Polar Surface Area:
150A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Literature
Title Journal
Evaluation of transport mechanism of prodrugs and parent drugs formed by intracellular metabolism in Caco-2 cells with modified carboxylesterase activity: temocapril as a model case. Journal of pharmaceutical sciences 20110901
Prediction of human intestinal absorption of the prodrug temocapril by in situ single-pass perfusion using rat intestine with modified hydrolase activity. Drug metabolism and disposition: the biological fate of chemicals 20110701
[A ten-year follow-up of a 109-year-old woman with myocardial infarction]. Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics 20110101
[Role of angiontensin receptors in remodeling perivascular nerves]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20101101
The effect of angiotensin-converting enzyme inhibitors of left atrial pressure in dogs with mitral valve regurgitation. Journal of veterinary internal medicine 20100101
Effect of angiotensin-converting enzyme inhibitor on serum asymmetric dimethylarginine and coronary circulation in patients with type 2 diabetes mellitus. International journal of cardiology 20090220
Olmesartan and temocapril prevented the development of hyperglycemia and the deterioration of pancreatic islet morphology in Otsuka-Long-Evans-Tokushima Fatty rats. Acta medica Okayama 20090201
In half of hypertensive diabetics, co-administration of a calcium channel blocker and an angiotensin-converting enzyme inhibitor achieved a target blood pressure of <130/80 mmHg: the azelnidipine and temocapril in hypertensive patients with type 2 diabetes (ATTEST) study. Hypertension research : official journal of the Japanese Society of Hypertension 20080801
Beneficial effects of olmesartan and temocapril on urinary liver-type fatty acid-binding protein levels in normotensive patients with immunoglobin A nephropathy. American journal of hypertension 20071101
Effects of monotherapy of temocapril or candesartan with dose increments or combination therapy with both drugs on the suppression of diabetic nephropathy. Hypertension research : official journal of the Japanese Society of Hypertension 20070401
Aldosterone breakthrough during therapy with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in proteinuric patients with immunoglobulin A nephropathy. Nephrology (Carlton, Vic.) 20061001
Angiotensin I-converting enzyme inhibitor improves reactive hyperemia in elderly hypertensives with arteriosclerosis obliterans. Hypertension research : official journal of the Japanese Society of Hypertension 20060901
Nephrotic syndrome and IgA nephropathy in polycystic kidney disease. Clinical and experimental nephrology 20060601
Effects of organic anion transporting polypeptide 1B1 haplotype on pharmacokinetics of pravastatin, valsartan, and temocapril. Clinical pharmacology and therapeutics 20060501
Effect on coronary flow velocity reserve in patients with type 2 diabetes mellitus: comparison between angiotensin-converting enzyme inhibitor and angiotensin II type 1 receptor antagonist. American heart journal 20060401
Angiotensin converting enzyme inhibitor attenuates oxidative stress-induced endothelial cell apoptosis via p38 MAP kinase inhibition. Clinica chimica acta; international journal of clinical chemistry 20060201
Identification of esterases expressed in Caco-2 cells and effects of their hydrolyzing activity in predicting human intestinal absorption. Drug metabolism and disposition: the biological fate of chemicals 20050801
Renin-angiotensin system modulates oxidative stress-induced endothelial cell apoptosis in rats. Hypertension (Dallas, Tex. : 1979) 20050601
Dual ECE/NEP inhibition on cardiac and neurohumoral function during the transition from hypertrophy to heart failure in rats. Hypertension (Dallas, Tex. : 1979) 20050601
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers effectively and directly potentiate superoxide scavenging by polymorphonuclear leukocytes from patients with type 2 diabetes mellitus. The American journal of the medical sciences 20050501
Long-term inhibition of angiotensin prevents reduction of periarterial innervation of calcitonin gene-related peptide (CGRP)-containing nerves in spontaneously hypertensive rats. Hypertension research : official journal of the Japanese Society of Hypertension 20050501
Endothelium-derived hydrogen peroxide accounts for the enhancing effect of an angiotensin-converting enzyme inhibitor on endothelium-derived hyperpolarizing factor-mediated responses in mice. Arteriosclerosis, thrombosis, and vascular biology 20050401
Different accumulation of temocapril and enalapril during repeated dosing in elderly patients. British journal of clinical pharmacology 20050401
Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats. Journal of the American Society of Nephrology : JASN 20050301
Angiotensin-converting-enzyme inhibitors slow renal decline in IgA nephropathy, independent of tubulointerstitial fibrosis at presentation. QJM : monthly journal of the Association of Physicians 20050301
ACE inhibitor and angiotensin II type 1 receptor blocker differently regulate ventricular fibrosis in hypertensive diastolic heart failure. Journal of hypertension 20050201
Exercise-related syncope induced by vasodilator therapy in an elderly hypertensive patient. Journal of the American Geriatrics Society 20050201
Insulin sensitivity and endothelial function in hypertension: a comparison of temocapril and candesartan. American journal of hypertension 20050201
Renal artery stenosis emerged after angiotensin-converting enzyme inhibitor treatment for myocardial infarction: a case report. Angiology 20050101
Low-dose combination therapy with temocapril and losartan reduces proteinuria in normotensive patients with immunoglobulin a nephropathy. Hypertension research : official journal of the Japanese Society of Hypertension 20041201
Blockade of the renin-angiotensin system decreases adipocyte size with improvement in insulin sensitivity. Journal of hypertension 20041001
Additive beneficial effects of the combination of a calcium channel blocker and an angiotensin blocker on a hypertensive rat-heart failure model. Hypertension research : official journal of the Japanese Society of Hypertension 20041001
Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress. Arteriosclerosis, thrombosis, and vascular biology 20040901
Salutary effects of attenuation of angiotensin II on coronary perivascular fibrosis associated with insulin resistance and obesity. Journal of molecular and cellular cardiology 20040801
Renoprotective effect of angiotensin-converting enzyme inhibitor combined with alpha1-adrenergic antagonist in spontaneously hypertensive rats with renal ablation. Hypertension research : official journal of the Japanese Society of Hypertension 20040701
AT1 receptor blocker added to ACE inhibitor provides benefits at advanced stage of hypertensive diastolic heart failure. Hypertension (Dallas, Tex. : 1979) 20040301
Regulation of skeletal muscle peroxisome proliferator-activated receptor gamma expression by exercise and angiotensin-converting enzyme inhibition in fructose-fed hypertensive rats. Hypertension research : official journal of the Japanese Society of Hypertension 20040101
Comparison of urinary excretion of pravastatin and temocapril in bile duct-ligated rats and Eisai hyperbilirubinemic rats (EHBR). Journal of hepato-biliary-pancreatic surgery 20040101
Pharmacological and clinical studies with temocapril, an angiotensin converting enzyme inhibitor that is excreted in the bile. Cardiovascular drug reviews 20040101
Effects of exercise training on glomerular structure in fructose-fed spontaneously hypertensive rats. Hypertension research : official journal of the Japanese Society of Hypertension 20031101
Successful treatment of severe hypertension with the combination of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker. Hypertension research : official journal of the Japanese Society of Hypertension 20031001
A newly developed angiotensin II type 1 receptor antagonist, CS866, promotes regression of cardiac hypertrophy by reducing integrin beta1 expression. Hypertension research : official journal of the Japanese Society of Hypertension 20030901
Evaluation of systemic blood NO dynamics by EPR spectroscopy: HbNO as an endogenous index of NO. American journal of physiology. Heart and circulatory physiology 20030801
Human-derived vascular smooth muscle cells produce angiotensin II by changing to the synthetic phenotype. Journal of cellular physiology 20030801
Beneficial effects of angiotensin-converting enzyme inhibition on sarcoplasmic reticulum function in the failing heart of the Dahl rat. Circulation journal : official journal of the Japanese Circulation Society 20030801
Efficacy of various antihypertensive agents as evaluated by indices of vascular stiffness in elderly hypertensive patients. Hypertension research : official journal of the Japanese Society of Hypertension 20030801
Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension. Hypertension (Dallas, Tex. : 1979) 20030701
Should increasing the dose or adding an AT1 receptor blocker follow a relatively low dose of ACE inhibitor initiated in acute myocardial infarction? Cardiovascular research 20030601
Temocapril treatment ameliorates autoimmune myocarditis associated with enhanced cardiomyocyte thioredoxin expression. Molecular and cellular biochemistry 20030601
[Temocapril treatment upregulated cardiomyocyte thioredoxin expression and improved autoimmune myocarditis]. Zhonghua nei ke za zhi 20030501
Temocapril prevents motor neuron damage and upregulation of cyclooxygenase-II in glutamate-induced neurotoxicity. Neurological research 20030401
Chronic angiotensin II inhibition increases levels of calcitonin gene-related peptide mRNA of the dorsal root ganglia in spontaneously hypertensive rats. Hypertension research : official journal of the Japanese Society of Hypertension 20030301
Effects of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on beta-adrenoceptor signaling in heart failure produced by myocardial Infarction in rabbits: reversal of altered expression of beta-adrenoceptor kinase and G i alpha. The Journal of pharmacology and experimental therapeutics 20030101
Beneficial effects of combination of ACE inhibitor and angiotensin II type 1 receptor blocker on cardiac remodeling in rat myocardial infarction. Cardiovascular research 20030101
Effects of temocapril and olmesartan on myocardial sympathetic nervous activity and fatty acid metabolism in rats with chronic beta-adrenergic stimulation. Journal of cardiovascular pharmacology 20030101
[Successful treatment of combination therapy using an angiotensin-converting enzyme inhibitor and an angiotensin II receptor blocker in a patient with IgA nephropathy]. Nihon Jinzo Gakkai shi 20030101
Antiproteinuric effects of combined antihypertensive therapies in patients with overt type 2 diabetic nephropathy. Hypertension research : official journal of the Japanese Society of Hypertension 20021101
Impact of exercise and angiotensin converting enzyme inhibition on tumor necrosis factor-alpha and leptin in fructose-fed hypertensive rats. Hypertension research : official journal of the Japanese Society of Hypertension 20021101
Chronic angiotensin-converting enzyme inhibition and angiotensin II antagonism in rats with chronic renal failure. Journal of cardiovascular pharmacology 20021001
An angiotensin-converting enzyme inhibitor, not an angiotensin II type-1 receptor blocker, prevents beta-aminopropionitrile monofumarate-induced aortic dissection in rats. Journal of vascular surgery 20021001
CS-886, a new angiotensin II type 1 receptor antagonist, ameliorates glomerular anionic site loss and prevents progression of diabetic nephropathy in Otsuka Long-Evans Tokushima fatty rats. Molecular medicine (Cambridge, Mass.) 20021001
ACE inhibitor improves insulin resistance in diabetic mouse via bradykinin and NO. Hypertension (Dallas, Tex. : 1979) 20020901
Inhibition of renin-angiotensin system ameliorates endothelial dysfunction associated with aging in rats. Arteriosclerosis, thrombosis, and vascular biology 20020901
[Effects of temocapril on the prevention of early diabetic nephropathy in OLETF rat, an animal model for type 2 diabetes]. [Hokkaido igaku zasshi] The Hokkaido journal of medical science 20020901
Beneficial effects of combined blockade of ACE and AT1 receptor on intimal hyperplasia in balloon-injured rat artery. Arteriosclerosis, thrombosis, and vascular biology 20020801
Combination therapy of exercise and angiotensin-converting enzyme inhibitor markedly improves insulin sensitivities in hypertensive patients with insulin resistance. Circulation journal : official journal of the Japanese Circulation Society 20020701
Differential effects of a long-acting angiotensin converting enzyme inhibitor (temocapril) and a long-acting calcium antagonist (amlodipine) on ventricular ectopic beats in older hypertensive patients. Hypertension research : official journal of the Japanese Society of Hypertension 20020501
Combination therapy with an angiotensin-converting enzyme (ACE) inhibitor and a calcium antagonist: beyond the renoprotective effects of ACE inhibitor monotherapy in a spontaneous hypertensive rat with renal ablation. Hypertension research : official journal of the Japanese Society of Hypertension 20020501
Combined effect of ACE inhibitor and exercise training on insulin resistance in type 2 diabetic rats. Life sciences 20020301
Inhibitory effect of a novel angiotensin II type 1 receptor antagonist RNH-6270 on growth of vascular smooth muscle cells from spontaneously hypertensive rats: different anti-proliferative effect to angiotensin-converting enzyme inhibitor. Journal of cardiovascular pharmacology 20020201
Temocapril, a long-acting non-SH group angiotensin converting enzyme inhibitor, modulates glomerular injury in chronic puromycin aminonucleoside nephrosis. Journal of nephrology 20020101
[Effects of CS-866, an angiotensin II receptor antagonist, in 5/6 nephrectomized spontaneously hypertensive rats]. Nihon Jinzo Gakkai shi 20011001
Effects of long-acting ACE inhibitor (temocapril) and long-acting Ca channel blocker (amlodipine) on 24-h ambulatory BP in elderly hypertensive patients. Journal of human hypertension 20010901
Differential subcellular actions of ACE inhibitors and AT(1) receptor antagonists on cardiac remodeling induced by chronic inhibition of NO synthesis in rats. Hypertension (Dallas, Tex. : 1979) 20010901
Differential effects of angiotensin II versus endothelin-1 inhibitions in hypertrophic left ventricular myocardium during transition to heart failure. Circulation 20010731
Angiotensin-converting enzyme inhibition attenuates hypofibrinolysis and reduces cardiac perivascular fibrosis in genetically obese diabetic mice. Circulation 20010626
Angiotensin blockade inhibits increased JNKs, AP-1 and NF- kappa B DNA-binding activities in myocardial infarcted rats. Journal of molecular and cellular cardiology 20010401
Effects of troglitazone and temocapril in spontaneously hypertensive rats with chronic renal failure. Journal of hypertension 20010301
Effect of temocapril hydrochloride on serum lipid levels in patients with hypertensive type 2 diabetes mellitus. Journal of atherosclerosis and thrombosis 20010101
Prevention of doxorubicin (adriamycin)-induced cardiomyopathy by simultaneous administration of angiotensin-converting enzyme inhibitor assessed by acoustic densitometry. Journal of cardiovascular pharmacology 20000901
Hydrolytic profile for ester- or amide-linkage by carboxylesterases pI 5.3 and 4.5 from human liver. Biological & pharmaceutical bulletin 19970801
Pharmacokinetics of temocapril, an ACE inhibitor with preferential biliary excretion, in patients with impaired liver function. European journal of clinical pharmacology 19930101
Pharmacokinetics of temocapril hydrochloride, a novel angiotensin converting enzyme inhibitor, in renal insufficiency. European journal of clinical pharmacology 19920101
Properties